The Brn-3a transcription factor plays a critical role in regulating human papilloma virus gene expression and determining the growth characteristics of cervical cancer cells

J Biol Chem. 1999 Oct 1;274(40):28521-7. doi: 10.1074/jbc.274.40.28521.

Abstract

The Brn-3a POU family transcription factor has previously been shown to activate the human papilloma virus type 16 (HPV-16) promoter driving the expression of the E6- and E7-transforming proteins. Moreover, Brn-3a is overexpressed approximately 300-fold in cervical biopsies from women with cervical intra-epithelial neoplasia type 3 (CIN3) compared with normal cervical material. To test the role of Brn-3a in cervical neoplasia we have manipulated its expression in cervical carcinoma-derived cell lines with or without endogenous HPV genes. In HPV-expressing cells, reduction in Brn-3a expression specifically reduces HPV gene expression, growth rate, saturation density and anchorage-independent growth, whereas these effects are not observed when Brn-3a expression is reduced in cervical cells lacking HPV genomes. Together with our previous observations, these findings indicate a critical role for Brn-3a in regulating HPV gene expression and thereby in controlling the growth/transformation of cervical cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Division / physiology*
  • DNA-Binding Proteins / physiology*
  • Dexamethasone / pharmacology
  • Female
  • Gene Expression Regulation, Viral / drug effects
  • Gene Expression Regulation, Viral / physiology*
  • Humans
  • Papillomaviridae / genetics*
  • Transcription Factor Brn-3
  • Transcription Factor Brn-3A
  • Transcription Factors / physiology*
  • Tumor Cells, Cultured
  • Uterine Cervical Neoplasms / pathology*
  • Uterine Cervical Neoplasms / virology

Substances

  • DNA-Binding Proteins
  • POU4F1 protein, human
  • Transcription Factor Brn-3
  • Transcription Factor Brn-3A
  • Transcription Factors
  • Dexamethasone